SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

BRIEF — Kexing Biopharm Biologics License Application For Long — Acting G — Csf Candidate GB — K02 Accepted For Review

Oct 16 (Reuters) — KEXING BIOPHARM: Kexing Biopharm: Co's Biologics License Application For Long-acting G-csf Candidate Gb-k02 Accepted For Review Source text:... (Reuters.Briefs@thomsonreuters.com;)

BRIEF